Completed NA INTERVENTIONAL 3-arm NCT05283408

The Clinical Study of Dexmedetomidine and Esketamine Combined Infusion Undergoing Modified Radical Mastectomy

Effect of Dexmedetomidine and Esketamine Combined Infusion on Postoperative Pain and Recovey Quality Undergoing Modified Radical Mastectomy

Sponsor: Anqing Municipal Hospital

Conditions Dexmedetomidine, Esketamine, Postoperative Pain and Recovery Quality

Interventions Co-administration dexmedetomidine and high-dose esketamine infusion Co-administration dexmedetomidine and low-dose esketamine infusion Dexmedetomidine infusion

Updated 6 times since 2022 Last updated: Apr 11, 2023 Started: Apr 10, 2022 Primary completion: Mar 20, 2023 Completion: Mar 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Dexmedetomidine, Esketamine, Postoperative Pain and Recovery Quality and is currently completed. Anqing Municipal Hospital leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2023 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Apr 2023 — May 2023 [monthly]

Recruiting NA
Jun 2022 — Apr 2023 [monthly]

Recruiting NA

▶ Show 1 earlier version

Apr 2022 — Jun 2022 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Anqing Municipal Hospital

Data source: Anqing Municipal Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Anqing, China